McKesson Co. (NYSE:MCK) is Stanley Capital Management LLC's 9th Largest Position

Stanley Capital Management LLC trimmed its stake in shares of McKesson Co. (NYSE:MCK - Free Report) by 18.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,500 shares of the company's stock after selling 7,700 shares during the quarter. McKesson comprises approximately 3.7% of Stanley Capital Management LLC's investment portfolio, making the stock its 9th biggest position. Stanley Capital Management LLC's holdings in McKesson were worth $19,092,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Gateway Investment Advisers LLC lifted its holdings in shares of McKesson by 25.6% during the fourth quarter. Gateway Investment Advisers LLC now owns 5,941 shares of the company's stock worth $3,386,000 after buying an additional 1,212 shares in the last quarter. Cypress Wealth Services LLC acquired a new stake in shares of McKesson during the fourth quarter worth $226,000. Merit Financial Group LLC lifted its holdings in shares of McKesson by 127.1% during the fourth quarter. Merit Financial Group LLC now owns 10,060 shares of the company's stock worth $5,734,000 after buying an additional 5,630 shares in the last quarter. Brooklyn Investment Group lifted its holdings in shares of McKesson by 2.6% during the fourth quarter. Brooklyn Investment Group now owns 1,068 shares of the company's stock worth $609,000 after buying an additional 27 shares in the last quarter. Finally, Integrated Investment Consultants LLC lifted its holdings in shares of McKesson by 3.9% during the fourth quarter. Integrated Investment Consultants LLC now owns 2,198 shares of the company's stock worth $1,253,000 after buying an additional 82 shares in the last quarter. 85.07% of the stock is owned by institutional investors.

McKesson Trading Down 0.2%

MCK stock traded down $1.24 during trading on Wednesday, hitting $717.95. The company had a trading volume of 812,321 shares, compared to its average volume of 917,162. The business has a 50-day moving average of $686.37 and a 200-day moving average of $630.52. McKesson Co. has a one year low of $464.42 and a one year high of $731.00. The stock has a market cap of $89.82 billion, a PE ratio of 32.87, a PEG ratio of 1.29 and a beta of 0.53.

McKesson (NYSE:MCK - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $10.12 EPS for the quarter, beating the consensus estimate of $9.83 by $0.29. McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. The business had revenue of $90.82 billion for the quarter, compared to analysts' expectations of $94 billion. During the same period in the prior year, the business posted $6.18 earnings per share. The firm's revenue was up 18.9% on a year-over-year basis. Research analysts forecast that McKesson Co. will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 1st. Shareholders of record on Monday, June 2nd will be issued a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.40%. The ex-dividend date is Monday, June 2nd. McKesson's payout ratio is 10.99%.

Insiders Place Their Bets

In other news, CEO Brian S. Tyler sold 8,961 shares of the company's stock in a transaction that occurred on Friday, February 21st. The stock was sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the transaction, the chief executive officer now directly owns 60,664 shares of the company's stock, valued at $36,276,465.36. This represents a 12.87% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CAO Napoleon B. Rutledge, Jr. sold 543 shares of the company's stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $726.51, for a total value of $394,494.93. Following the transaction, the chief accounting officer now directly owns 1,972 shares in the company, valued at $1,432,677.72. The trade was a 21.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.11% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms recently commented on MCK. Morgan Stanley boosted their price target on McKesson from $642.00 to $745.00 and gave the company an "overweight" rating in a research note on Wednesday, April 2nd. UBS Group boosted their target price on McKesson from $708.00 to $805.00 and gave the stock a "buy" rating in a research note on Tuesday, April 29th. Mizuho boosted their target price on McKesson from $630.00 to $690.00 and gave the stock a "neutral" rating in a research note on Thursday, April 3rd. StockNews.com downgraded McKesson from a "strong-buy" rating to a "buy" rating in a research note on Wednesday. Finally, Bank of America boosted their target price on McKesson from $755.00 to $800.00 and gave the stock a "buy" rating in a research note on Friday, May 9th. Three equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, McKesson has a consensus rating of "Moderate Buy" and a consensus target price of $686.69.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.